Previous studies indicated that the CCL2‐CCR2 signalling axis played a role in the promotion of pathological angiogenesis, the survival and invasion of tumour cells, and the recruitment of immune inhibitory cells.17, 18, 19. The gene discussed is CCR2; the disease is neoplasm.